 Regeneron Pharmaceuticals Inc  USA Stock   USD 438.78 3.78 0.85% 
Regeneron Pharmaceuticals Inc holds
Coefficient Of Variation of 1538.26,
Semi Deviation of 1.02 and
Risk Adjusted Performance of 0.0232. Compared with
Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of Regeneron Pharmaceuticals as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen
technical drivers for Regeneron Pharmaceuticals which can be compared to its competitors. Please check
Regeneron Pharmaceuticals Downside Deviation,
Jensen Alpha as well as the
relationship between Jensen Alpha and
Downside Variance to decide if Regeneron Pharmaceuticals is priced somewhat accurately providing market reflects its current price of 438.78 per share. Given that Regeneron Pharmaceuticals has
Jensen Alpha of
(0.15), we recommend you check out Regeneron Pharmaceuticals recent market performance to make sure the company can sustain itself at future point.
Investment Horizon

30 Days
Login
to change

Regeneron Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Regeneron Pharmaceuticals Inc. You can use it to identify possible trend reversals for Regeneron Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Regeneron Pharmaceuticals price movement. To start drawing, click on the pencil icon on topright. To remove the trend, use eraser icon.
Regeneron Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Regeneron Pharmaceuticals Inc applied against its price change over selected period. The best fit line has a slop of
0.17 % which means Regeneron Pharmaceuticals Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 24.69, which is the sum of squared deviations for the predicted Regeneron Pharmaceuticals price change compared to its average price change.
  Performance AnalysisCheck effects of meanvariance optimization against your current asset allocation 
Regeneron Pharmaceuticals Inc is rated
third in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about
1.29 of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Regeneron Pharmaceuticals Inc is roughly
1.29